{
    "2019-10-09": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Clovis (CLVS) Shares Drop on Goldman Sachs' Bearish Outlook",
                "features": {
                    "keywords": [
                        "Clovis",
                        "Bearish Outlook",
                        "Goldman Sachs"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "Biotech Stock Roundup: GILD's Descovy Label Expansion Gets FDA Nod & Other Updates",
                "features": {
                    "keywords": [
                        "GILD",
                        "Descovy",
                        "FDA Nod",
                        "Label Expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "Nektar's Shares Drop on Rating Downgrade by Goldman Sachs",
                "features": {
                    "keywords": [
                        "Nektar",
                        "Rating Downgrade",
                        "Goldman Sachs"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}